$289.68 Million in Sales Expected for Ceridian HCM Holding Inc. (NYSE:CDAY) This Quarter

Wall Street analysts forecast that Ceridian HCM Holding Inc. (NYSE:CDAY – Get Rating) will announce sales of $289.68 million for the current quarter, Zacks reports. Six analysts have provided estimates for Ceridian HCM’s earnings, with the highest sales estimate coming in at $290.90 million and the lowest estimate coming in at $288.80 million. Ceridian HCM posted sales of $234.50 million in the same quarter last year, which suggests a positive year-over-year growth rate of 23.5%. The company is expected to report its next quarterly earnings results after the market closes on Monday, January 1st.

According to Zacks, analysts expect that Ceridian HCM will report full-year sales of $1.21 billion for the current financial year, with estimates ranging from $1.20 billion to $1.21 billion. For the next year, analysts forecast that the firm will post sales of $1.41 billion, with estimates ranging from $1.38 billion to $1.44 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side analysts that cover Ceridian HCM.

Ceridian HCM (NYSE:CDAY – Get Rating) last issued its earnings results on Wednesday, February 9th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.02). The firm had revenue of $282.10 million during the quarter, compared to analysts’ expectations of $274.98 million. Ceridian HCM had a negative return on equity of 2.73% and a negative net margin of 7.36%. During the same period last year, the firm posted ($0.02) earnings per share.

Several brokerages have issued reports on CDAY. Piper Sandler decreased their target price on shares of Ceridian HCM from $105.00 to $85.00 and set a “neutral” rating for the company in a report on Thursday, February 10th. Barclays decreased their target price on shares of Ceridian HCM from $83.00 to $60.00 and set an “underweight” rating for the company in a report on Tuesday, April 19th. Deutsche Bank Aktiengesellschaft decreased their target price on shares of Ceridian HCM from $110.00 to $105.00 and set a “buy” rating for the company in a report on Thursday, February 10th. Mizuho decreased their price objective on shares of Ceridian HCM from $140.00 to $100.00 and set a “buy” rating for the company in a report on Friday, January 28th. Finally, Wolfe Research cut shares of Ceridian HCM from a “peer perform” rating to an “underperform” rating in a report on Friday, February 11th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat, Ceridian HCM has a consensus rating of “Hold” and an average target price of $96.45.

Shares of Ceridian HCM stock opened at $56.72 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 1.11. The stock has a market capitalization of $8.62 billion, a PE ratio of -113.44 and a beta of 1.47. Ceridian HCM has a 52-week low of $56.70 and a 52-week high of $130.37. The company has a 50-day simple moving average of $65.93 and a two-hundred day simple moving average of $90.29.

In other news, insider Jeffrey Scott Jacobs sold 784 shares of the company’s stock in a transaction on Wednesday, March 9th. The stock was sold at an average price of $62.49, for a total value of $48,992.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Christopher R. Armstrong sold 3,891 shares of the company’s stock in a transaction on Wednesday, February 9th. The stock was sold at an average price of $79.48, for a total value of $309,256.68. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,353 shares of company stock valued at $900,537. Company insiders own 3.90% of the company’s stock.

Several large investors have recently bought and sold shares of the company. Metropolitan Life Insurance Co NY boosted its holdings in Ceridian HCM by 35.4% in the 1st quarter. Metropolitan Life Insurance Co NY now owns 3,655 shares of the company’s stock worth $187,000 after buying an additional 955 shares during the period. First Trust Advisors LP bought a new position in Ceridian HCM in the 1st quarter worth $6,042,000. Morgan Stanley boosted its holdings in Ceridian HCM by 3.7% in the 2nd quarter. Morgan Stanley now owns 532,360 shares of the company’s stock worth $51,065,000 after buying an additional 18,865 shares during the period. Commonwealth Equity Services LLC bought a new position in Ceridian HCM in the 3rd quarter worth $343,000. Finally, Hartford Investment Management Co. bought a new position in Ceridian HCM in the 3rd quarter worth $1,416,000.

Ceridian HCM Company Profile (Get Rating)

Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.

Read More